These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
290 related articles for article (PubMed ID: 30511419)
1. GRK5 influences the phosphorylation of tau via GSK3β and contributes to Alzheimer's disease. Zhao J; Li X; Chen X; Cai Y; Wang Y; Sun W; Mai H; Yang J; Fan W; Tang P; Ou M; Zhang Y; Huang X; Zhao B; Cui L J Cell Physiol; 2019 Jul; 234(7):10411-10420. PubMed ID: 30511419 [TBL] [Abstract][Full Text] [Related]
2. GRK5 dysfunction accelerates tau hyperphosphorylation in APP (swe) mice through impaired cholinergic activity. Zhang Y; Chen L; Shen G; Zhao Q; Shangguan L; He M Neuroreport; 2014 May; 25(7):542-7. PubMed ID: 24598771 [TBL] [Abstract][Full Text] [Related]
3. Atorvastatin ameliorates cognitive impairment, Aβ1-42 production and Tau hyperphosphorylation in APP/PS1 transgenic mice. Zhou D; Liu H; Li C; Wang F; Shi Y; Liu L; Zhao X; Liu A; Zhang J; Wang C; Chen Z Metab Brain Dis; 2016 Jun; 31(3):693-703. PubMed ID: 26883430 [TBL] [Abstract][Full Text] [Related]
4. FLZ alleviates the memory deficits in transgenic mouse model of Alzheimer's disease via decreasing beta-amyloid production and tau hyperphosphorylation. Bao XQ; Li N; Wang T; Kong XC; Tai WJ; Sun H; Zhang D PLoS One; 2013; 8(11):e78033. PubMed ID: 24223757 [TBL] [Abstract][Full Text] [Related]
5. Fuzhisan ameliorates Aβ production and tau phosphorylation in hippocampal of 11month old APP/PS1 transgenic mice: A Western blot study. Zhang ZX; Zhao RP; Wang DS; Wang AN Exp Gerontol; 2016 Nov; 84():88-95. PubMed ID: 27612601 [TBL] [Abstract][Full Text] [Related]
6. GSK3β is involved in promoting Alzheimer's disease pathologies following chronic systemic exposure to Porphyromonas gingivalis lipopolysaccharide in amyloid precursor protein Jiang M; Zhang X; Yan X; Mizutani S; Kashiwazaki H; Ni J; Wu Z Brain Behav Immun; 2021 Nov; 98():1-12. PubMed ID: 34391814 [TBL] [Abstract][Full Text] [Related]
7. Neuroprotective effects of regulators of the glycogen synthase kinase-3beta signaling pathway in a transgenic model of Alzheimer's disease are associated with reduced amyloid precursor protein phosphorylation. Rockenstein E; Torrance M; Adame A; Mante M; Bar-on P; Rose JB; Crews L; Masliah E J Neurosci; 2007 Feb; 27(8):1981-91. PubMed ID: 17314294 [TBL] [Abstract][Full Text] [Related]
8. Neuropathogenic role of adenylate kinase-1 in Aβ-mediated tau phosphorylation via AMPK and GSK3β. Park H; Kam TI; Kim Y; Choi H; Gwon Y; Kim C; Koh JY; Jung YK Hum Mol Genet; 2012 Jun; 21(12):2725-37. PubMed ID: 22419736 [TBL] [Abstract][Full Text] [Related]
9. Deletion of Type-2 Cannabinoid Receptor Induces Alzheimer's Disease-Like Tau Pathology and Memory Impairment Through AMPK/GSK3β Pathway. Wang L; Liu BJ; Cao Y; Xu WQ; Sun DS; Li MZ; Shi FX; Li M; Tian Q; Wang JZ; Zhou XW Mol Neurobiol; 2018 Jun; 55(6):4731-4744. PubMed ID: 28717968 [TBL] [Abstract][Full Text] [Related]
10. Isorhynchophylline ameliorates cognitive impairment via modulating amyloid pathology, tau hyperphosphorylation and neuroinflammation: Studies in a transgenic mouse model of Alzheimer's disease. Li HQ; Ip SP; Yuan QJ; Zheng GQ; Tsim KKW; Dong TTX; Lin G; Han Y; Liu Y; Xian YF; Lin ZX Brain Behav Immun; 2019 Nov; 82():264-278. PubMed ID: 31476414 [TBL] [Abstract][Full Text] [Related]
11. Targeting CCR3 to Reduce Amyloid-β Production, Tau Hyperphosphorylation, and Synaptic Loss in a Mouse Model of Alzheimer's Disease. Zhu C; Xu B; Sun X; Zhu Q; Sui Y Mol Neurobiol; 2017 Dec; 54(10):7964-7978. PubMed ID: 27878757 [TBL] [Abstract][Full Text] [Related]
12. Interplay between cyclin-dependent kinase 5 and glycogen synthase kinase 3 beta mediated by neuregulin signaling leads to differential effects on tau phosphorylation and amyloid precursor protein processing. Wen Y; Planel E; Herman M; Figueroa HY; Wang L; Liu L; Lau LF; Yu WH; Duff KE J Neurosci; 2008 Mar; 28(10):2624-32. PubMed ID: 18322105 [TBL] [Abstract][Full Text] [Related]
13. Qingxin Kaiqiao Fang decreases Tau hyperphosphorylation in Alzheimer's disease via the PI3K/Akt/GSK3β pathway in vitro and in vivo. Liu S; Xu L; Shen Y; Wang L; Lai X; Hu H J Ethnopharmacol; 2024 Jan; 318(Pt B):117031. PubMed ID: 37579924 [TBL] [Abstract][Full Text] [Related]
14. [Puerarin alleviates cognitive impairment and tau hyperphosphorylation in APP/PS1 transgenic mice]. Mei ZR; Tan XP; Liu SZ; Huang HH Zhongguo Zhong Yao Za Zhi; 2016 Sep; 41(17):3285-3289. PubMed ID: 28920384 [TBL] [Abstract][Full Text] [Related]
15. Long-term exposure to ELF-MF ameliorates cognitive deficits and attenuates tau hyperphosphorylation in 3xTg AD mice. Hu Y; Lai J; Wan B; Liu X; Zhang Y; Zhang J; Sun D; Ruan G; Liu E; Liu GP; Chen C; Wang DW Neurotoxicology; 2016 Mar; 53():290-300. PubMed ID: 26945731 [TBL] [Abstract][Full Text] [Related]
16. Caspase-3-dependent cleavage of Akt modulates tau phosphorylation via GSK3β kinase: implications for Alzheimer's disease. Chu J; Lauretti E; Praticò D Mol Psychiatry; 2017 Jul; 22(7):1002-1008. PubMed ID: 28138159 [TBL] [Abstract][Full Text] [Related]
17. Soluble amyloid precursor protein alpha inhibits tau phosphorylation through modulation of GSK3β signaling pathway. Deng J; Habib A; Obregon DF; Barger SW; Giunta B; Wang YJ; Hou H; Sawmiller D; Tan J J Neurochem; 2015 Nov; 135(3):630-7. PubMed ID: 26342176 [TBL] [Abstract][Full Text] [Related]
18. Myricetin ameliorates cognitive impairment in 3×Tg Alzheimer's disease mice by regulating oxidative stress and tau hyperphosphorylation. Wang L; Tang Z; Li B; Peng Y; Yang X; Xiao Y; Ni R; Qi XL Biomed Pharmacother; 2024 Aug; 177():116963. PubMed ID: 38889642 [TBL] [Abstract][Full Text] [Related]
19. Micro-RNA-137 Inhibits Tau Hyperphosphorylation in Alzheimer's Disease and Targets the CACNA1C Gene in Transgenic Mice and Human Neuroblastoma SH-SY5Y Cells. Jiang Y; Xu B; Chen J; Sui Y; Ren L; Li J; Zhang H; Guo L; Sun X Med Sci Monit; 2018 Aug; 24():5635-5644. PubMed ID: 30102687 [TBL] [Abstract][Full Text] [Related]
20. SLOH, a carbazole-based fluorophore, mitigates neuropathology and behavioral impairment in the triple-transgenic mouse model of Alzheimer's disease. Wu X; Kosaraju J; Zhou W; Tam KY Neuropharmacology; 2018 Mar; 131():351-363. PubMed ID: 29309769 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]